Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity was posted on December 5, 2014. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

EXPi293 Expression Medium Reagent

Closed
NIAID-NOI-15B-1711158Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

20 days ago

DEADLINE

in 21 days

General Info

Agency

N/A

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), BETHESDA, MD, 20892, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Nancy E. NannettiPurchasing Agent
Sylvia Kate - RobinsonContracting Officer

Full Description

Show more
The National Institute of Allergy and Infectious Diseases (NIAID) in support of VRC intends to negotiate an other than full and open competition an order for 500 vials of EXPi293 Expression Medium reagent with Life Technologies. 5971 Van Allen Way, Carlsbad, CA, 92008-7313. Life Technologies is the original manufacturer (OEM) of the reagent. The Expi293TM Expression Medium is a chemically-defined, serum-free, protein-free medium for growth and transfection of suspension-adapted human embryonic kidney (HEK) 293 cells. It is specifically designed as a core component to support high density cultures of Expi293FTM cells in the Expi293TM Expression System for scalable transient protein expression. This is not a request for proposal. All responsible sources who can show capability to produce this reagent may submit a proposal with a statement of capabilities to indicate product specifications and past performance producing the same or similar reagents. All responses will be considered. The Government reserves the right to make a decision whether to this requirement is available for competition. All responses shall be submitted via the US Postal Service to: Nancy Nannetti, 5601 Fishers Lane, Room 3A54, Rockville, MD 20852 no later than December 22, 2014 by 2:00pm EST. E-mail submissions will be accepted at nannettn@mail.nih.gov. Fax and collect calls will not be accepted

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS